1450 Results

People

  1. Kolesnick
    Kolesnick
  2. Fuks
    Fuks
  3. Pandolfi Derinaldis
    Pandolfi Derinaldis
  4. Schwartz
    Schwartz
  5. Haimovitz-Friedman
    Haimovitz-Friedman
  6. Cordon-Cardo
    Cordon-Cardo
  7. Marks
    Marks
  8. Strauss
    Strauss
  9. Jiang
    Jiang
  10. Rosen
    Rosen

Groups

  1. GSK Faculty (535)
  2. Sloan Kettering Institute Faculty (452)
  3. Department of Medicine (418)
  4. Molecular Pharmacology and Chemistry Program Faculty (232)
  5. Sloan Kettering Institute Postdocs (199)
  6. Solid Tumor Oncology Division (183)
  7. Center for Hematologic Malignancies (171)
  8. Surgery (143)
  9. Hematologic Malignancies, Division of (138)
  10. Division of Subspecialty Medicine (126)
  1. "apoptosis"
Formats
  1. Journal Article (1311)
  2. Meeting Abstract (69)
  3. Review (36)
  4. Editorial (15)
  5. Conference Paper (11)
  6. Research Letter (4)
  7. Book Section (2)
  8. Guidelines (2)
Groups
  1. GSK Faculty (535)
  2. Sloan Kettering Institute Faculty (452)
  3. Department of Medicine (418)
  4. Molecular Pharmacology and Chemistry Program Faculty (232)
  5. Sloan Kettering Institute Postdocs (199)
  6. Solid Tumor Oncology Division (183)

More Groups

People
  1. Richard Kolesnick (107)
  2. Zvi Fuks (73)
  3. Pier Pandolfi Derinaldis (69)
  4. Gary Schwartz (63)
  5. Adriana Haimovitz-Friedman (62)
  6. Carlos Cordon-Cardo (60)

More People

Years
  1. 2025 (21)
  2. 2024 (63)
  3. 2023 (30)
  4. 2022 (27)
  5. 2021 (20)
  6. 2020 (24)

More Years

Publications
  1. Cancer Research (102)
  2. Proceedings of the National Academy of Sciences of the United States of America (68)
  3. Clinical Cancer Research (55)
  4. Blood (43)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (38)
  6. Journal of Biological Chemistry (37)

More Publications

Publishers
  1. American Association for Cancer Research (223)
  2. Nature Publishing Group (183)
  3. Elsevier Inc. (99)
  4. Cell Press (81)
  5. National Academy of Sciences (68)
  6. Springer (57)

More Publishers

Results (1450)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Brief report: Safety and antitumor activity of durvalumab plus tremelimumab in programmed cell death-(ligand)1–monotherapy pretreated, advanced NSCLC: Results from a phase 1b clinical trial
    Journal Article

    Garon, E. B.; Spira, A. I.; Goldberg, S. B.; Chaft, J. E.; Papadimitrakopoulou, V.; Cascone, T.; Antonia, S. J.; Brahmer, J. R.; Camidge, D. R.; Powderly, J. D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
    Journal Article

    Adzibolosu, N.; Alvero, A. B.; Ali-Fehmi, R.; Gogoi, R.; Corey, L.; Tedja, R.; Chehade, H.; Gogoi, V.; Morris, R.; Anderson, M.; more...
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • Pharmacologic features of drugs targeting BCL2 family members
    Book Section

    Lue, J. K.; O'Connor, O. A.
    In O'Connor, O. A.; Ansell, S. M.; Seymour, J. F. (Eds.) Precision Cancer Therapies (2023)

    Fulltext@MSK | Save
  • 5-alpha reductase inhibitors use in prostatic disease and beyond
    Review

    Chislett, B.; Chen, D.; Perera, M. L.; Chung, E.; Bolton, D.; Qu, L. G.
    Translational Andrology and Urology (2023)

    Fulltext@MSK | Save
  • Apoptotic cell death in disease—Current understanding of the NCCD 2023
    Review

    Vitale, I.; Pietrocola, F.; Guilbaud, E.; Aaronson, S. A.; Abrams, J. M.; Adam, D.; Agostini, M.; Agostinis, P.; Alnemri, E. S.; Altucci, L.; more...
    Cell Death and Differentiation (2023)

    Fulltext@MSK | Save
  • cGASing mitochondria to fend off ferroptosis
    Editorial

    Wang, H.; Jiang, X.
    Cell Research (2023)

    Fulltext@MSK | Save
  • Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax
    Journal Article

    Satta, T.; Li, L.; Chalasani, S. L.; Hu, X.; Nkwocha, J.; Sharma, K.; Kmieciak, M.; Rahmani, M.; Zhou, L.; Grant, S.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
    Journal Article

    Portelinha, A.; da Silva Ferreira, M.; Erazo, T.; Jiang, M.; Asgari, Z.; de Stanchina, E.; Younes, A.; Wendel, H. G.
    Nature Communications (2023)

    Fulltext@MSK | Save
  • OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis
    Journal Article

    Lee, S. A.; Chang, L. C.; Jung, W. R.; Bowman, J. W.; Kim, D.; Chen, W.; Foo, S. S.; Choi, Y. J.; Choi, U. Y.; Bowling, A.; more...
    Nature Cell Biology (2023)

    Fulltext@MSK | Save